Follow Tom On:
Categories
-
Recent Posts
- Better? Worse? Or The Same?: “WHO Disability Assessment Schedule (WHODAS 2.0)”
- Linking To The Results Of A Google Search: The Global Assessment Of Functioning With An Additional Link To WHODAS 2.0
- Linking To And Embedding Metabolic Mind’s CME “Cardiovascular Safety Of Ketogenic Therapy”
- Google Search Results: “HOMA-IR (Homeostasis Model Assessment of Insulin Resistance)”
- Linking To And Embedding Metabolic Mind CME’s “The Evidence Supporting Ketogenic Therapy for the Treatment of Serious Mental Illness”
- Linking To And Excerpting From Diabetes Research And Clinical Practice’s “5-Year effects of a novel continuous remote care model with carbohydrate-restricted nutrition therapy including nutritional ketosis in type 2 diabetes: An extension study”
- Linking To The All ARUP Consult Genetics Content
- Linking To The ARUP Consult Test Fact Sheets
- Linking To The ARUP Consult Topics
- Linking To The ARUP Consult Testing Algorithms
- Exploring ARUP Laboratories’ Outstanding Clinical Resources
- Linking To And Embedding CessSim’s “How I Would Start Flight Simming After 50 Without Spending Heaps!”
- Linking To And Embedding Dr. Nick Norwitz’s “Why I’m Not Afraid of Alzheimer’s Anymore”
- Linking To And Excerprting From CoreIM’s “Lp(a) and ASCVD Risk: 5 Pearls Segment”
- Linking To, Embedding, And Excerpting From Dr. Nick Norwitz’ “Lp(a) Explained: Genetics, Risk, and What You Can Actually Do”
- Linking To And Embedding Dr. Nick Norwitz’s “Glucose Game-Changer: 5-Year Study Proves Remission is Possible”
- Linking To And Excerpting From Circulation’s “Apolipoprotein B: Bridging the Gap Between Evidence and Clinical Practice”
- Linking To And Embedding Dr. Nick Norwitz’s “Glucose Game-Changer: 5-Year Study Proves Remission is Possible”
- Linking To And Embedding Dr. Nick Norwitz’s “Better Than Statins? The Truth About the New Cholesterol Drug” [The PCSK9 Inhibitor Evolocumab (Repatha)
- Linking To, Embedding, And Excerpting From Metabolic Mind’s “ApoB Explained: What Your LDL Test Doesn’t Tell You” With Additional Resources
- Linking To And Excerpting From The European Journal Of Pediatrics’ “Point‑of‑care ultrasound (POCUS) protocol for systematic assessment of the crashing neonate—expert consensus statement of the international crashing neonate working group”
- Linking To And Exploring The HealthMeasures Website: “Transforming How Health Is Measured”
- Results of Google Search “Patient-Reported Outcome Measures (PROMs)”
- Linking To And Embedding Encephalitis International’s “Diagnosis and misdiagnosis of autoimmune encephalitis with Professor Irani”
- Linking To And Embedding Core IM’s “Imaging for Acute Cholecystitis: ultrasound vs MRCP vs. CT vs. HIDA”
- Linking To And Embedding National Neonatal POCUS Collaborative’s “Raising the Bar: Training and QA Framework for Safe Neonatal Ultrasound Practice – NPC Webinar”
- Linking To And Embedding NeoCardio Lab’s “Delphi 2024 Crashing Neonate POCUS workshop by Dr Lauren Ruoss”
- Linking To And Embedding National Neonatal POCUS Collaborative’s “Targeted Use of POCUS for a Crashing Infant in the NICU: SAFE-R Protocol”
- Linking To And Embedding The National Neonatal POCUS Collaborative’s “Unveil the Unknown With “The Crashing Infant Protocol” November 28, 2023″
- Linking To And Embedding Metabolic Mind CME’s “Brain Energy: The Metabolic Theory of Mental Illness”
Category Archives: Preventive Medicine
Should We Prescribe Cholesterol Lowering Medicines to People at Relatively Low Risk of Heart Disease?
Dr. Topol is one of the most respected physicians in the country. And he believes that the risks of statins (cholesterol lowering drugs) when prescribed for persons without evidence of coronary artery disease (no history of previous heart attack) outweighs … Continue reading
Posted in Cardiology, Internal Medicine, Preventive Medicine
Comments Off on Should We Prescribe Cholesterol Lowering Medicines to People at Relatively Low Risk of Heart Disease?